Longmaster Information & Technology Co., Ltd.: history, ownership, mission, how it works & makes money

Founded in Guiyang in 1998, Longmaster Information & Technology Co., Ltd. (SZSE: 300288) has evolved from a regional tech firm into a national internet medical services leader, expanding into telemedicine and online hospitals in 2013, co-leading the Medical and Health Big Data Professional Committee by 2019, and securing a three-year high‑tech enterprise re‑certification in 2024; today it operates four business segments-Value‑added Telecommunications, Medical Information Services, Healthcare and Others-delivering telemedicine via the GuiHealth platform and the 39 Internet Hospital APP, partnering with China Telecom, China Unicom and China Mobile, serving specialties such as cardiology and oncology, and monetizing through remote consultations, online hospital solutions, smart health devices and pharmaceutical e‑commerce, supported by a registered capital of 330 million yuan, a workforce of 810 staff as of December 2024 (a 7.32% year‑on‑year decline), and a market capitalization of about 4.80 billion yuan with a stock price of 14.18 yuan as of October 2025-read on to explore Longmaster's ownership shifts, mission, operational model and revenue streams in detail.

Longmaster Information & Technology Co., Ltd. (300288.SZ) - Intro

• Founded: 1998; Headquarters: Guiyang, Guizhou, China
• Stock code: 300288.SZ; Market capitalization (2025): ≈ ¥4.80 billion
• Employees (Dec 2024): 810 (down 7.32% year-over-year)
• High-tech enterprise re-certification: achieved in 2024 (valid for three years)

• 1998 - Company founded in Guiyang, initially focused on medical information systems and healthcare IT services.
• 2013 - Strategic expansion into internet medical treatment: launched telemedicine services and began building online hospital solutions to connect patients with clinicians remotely.
• 2019 - Led establishment of the Medical and Health Big Data Professional Committee within the Guizhou Big Data Innovation Base, strengthening its role in regional health-data governance and industry standards.
• 2024 - Re-certified as a high-tech enterprise for a three-year period, enhancing R&D credibility and access to policy incentives.
• 2025 - Market capitalization reached approximately ¥4.80 billion, reflecting investor valuation tied to digital healthcare growth.

• Software products and platform subscriptions: licensing fees and SaaS subscriptions for hospital information systems, telemedicine platforms and online-hospital operations.
• Telemedicine and online-consultation services: transaction fees, service commissions and value-added charges for remote diagnosis, follow-up and chronic disease management.
• Data services and analytics: selling or licensing aggregated health-data products, analytics tools and decision-support modules to healthcare institutions and government bodies.
• Integration and implementation services: one-time project revenues from system integration, deployment, training and customization for medical institutions.
• Government and institutional contracts: procurement-driven revenues from regional health programs, public-health initiatives and digital-health infrastructure projects.

• Staffing and efficiency: 810 employees as of Dec 2024, a 7.32% decrease versus 2023, suggesting operational optimization or restructuring to improve margins and focus R&D resources.
• R&D orientation: high-tech enterprise status (2024-2027) supports continued investment in medical AI, data security and platform scalability.

Longmaster Information & Technology Co., Ltd. (300288.SZ): History

• Established focus: healthcare IT, internet medical platforms, enterprise digital solutions.
• Registered capital: 330 million yuan, supporting R&D and platform rollout.
• National recognition: designated a key software enterprise in national planning for five consecutive years.
• Industry accolade: shortlisted among China's top 100 internet medical enterprises in 2019.

• Controlling shareholder: Wang Wei and concerted parties - total 33.77% as of April 2025, after reducing holdings by 0.79%.
• Free float and institutional holders: remaining ~66.23%, including mutual funds, insurance and strategic partners (detailed registry filings for exact holders available in company disclosures).
• Listed status: public equity on Shenzhen Stock Exchange enables secondary market liquidity and institutional participation.

• Mission: provide integrated digital healthcare solutions to improve clinical workflows, patient engagement and administrative efficiency.
• Strategic emphasis: combine software IP, cloud deployment and data services to deliver recurring-license and SaaS revenue streams.

• Software licensing: on-premise and cloud-based EHR, HIS and specialty modules sold to hospitals and clinics.
• SaaS & subscription services: recurring fees for cloud-hosted platforms and data services.
• Integration & customization: one-time professional services for system integration and deployment.
• Managed services & maintenance: ongoing contracts for system upkeep, upgrades and support.
• Value-added services: data analytics, telemedicine modules and third-party marketplace transactions.

Longmaster Information & Technology Co., Ltd. (300288.SZ): Ownership Structure

• Mission: Integrate technology with healthcare to provide accessible, efficient medical services via digital platforms.
• Core focuses: telemedicine, medical information services, smart health monitoring, standardized service delivery.
• Collaboration: partnerships with medical institutions, clinical experts and technology companies to broaden service capabilities.
• Accessibility: targeted deployment of internet-based solutions to underserved regions and community-level healthcare providers.
• Patient-centricity: standardized, high-quality services emphasizing patient outcomes and data-driven care.
• R&D commitment: continuous investment in digital health research, platform upgrades and AI-enabled clinical tools.

• How it makes money:
  • Platform fees and subscriptions from hospitals and clinics for HIS/EHR integration, telemedicine gateways and SaaS services.
  • Per-consultation or service fees from telemedicine and online diagnosis/triage services.
  • Software licensing, implementation and maintenance contracts with medical institutions.
  • Sales of smart health devices and monitoring solutions, plus recurring data/analytics services.
  • Value-added services: training, clinical decision support, third‑party content and data monetization where compliant.
• Ownership highlights:
  • Founders and management hold meaningful stakes that align incentives with long-term platform growth.
  • Institutional investors (domestic mutual funds, insurance-linked funds) represent significant free-float ownership.
  • Strategic partners (medical groups, tech firms) may hold minority positions or enter JV arrangements to scale services.

Longmaster Information & Technology Co., Ltd. (300288.SZ): Mission and Values

• Business model: four operating segments - Value-added Telecommunications, Medical Information Services, Healthcare, and Others.
• Telemedicine delivery: GuiHealth platform for remote consultations targeting serious and complex illnesses.
• Remote clinical services via the 39 Internet Hospital APP: critical care consultations, teaching rounds, outpatient clinics, imaging consultations, and on-site assistance.
• Strategic carriers: long-term technical and connectivity partnerships with China Telecom, China Unicom, and China Mobile.
• Clinical strengths: accumulated experience in cardiology, respiratory diseases, internal medicine, gynecology, and oncology.

• Connectivity layer: carrier-grade links and co‑operation with China Telecom/Unicom/Mobile to deliver low-latency, secure video and data services.
• Platform layer: GuiHealth and 39 Internet Hospital APP provide scheduling, teleconsultation, image exchange, EMR integration, and analytics.
• Clinical services: multi-disciplinary remote consultation teams, specialty SOPs, and standardized teaching rounds to elevate lower-tier hospital care.
• Commercial layer: contracts with hospitals, provincial health authorities, and pay-per-service or subscription arrangements for platform access and professional services.

• Service fees from hospitals and healthcare institutions for platform deployment, maintenance, and per-consultation charges.
• Value-added telecommunications revenues from carrier services, connectivity packages, and platform data transmission.
• Clinical service contracts and revenue-sharing for telemedicine, remote imaging reads, and specialist consultations.
• Healthcare product sales, training programs, and platform licensing (one-time deployment fees plus recurring SaaS-like maintenance).

• 39 Internet Hospital APP capabilities: remote critical care consultations, live teaching rounds, remote outpatient clinics, imaging consultation workflows, and on-site assistance modules.
• GuiHealth: positioned for serious-disease referral consultations and multi-center case discussion to support complex clinical decision-making.
• Hospital management impact: platform-driven standardization of clinical pathways and documentation aimed at reducing adverse events and dispute incidence.
• Partnership leverage: integration with China Telecom/Unicom/Mobile improves reach into rural/regional hospitals and ensures reliable telemedicine sessions.

• Cardiology - remote ECG/echo consultation, critical care cardiology rounds.
• Respiratory diseases - tele-ICU support and chronic disease management.
• Internal medicine - complex case consultations and multi-disciplinary team (MDT) sessions.
• Gynecology - remote prenatal and specialist consults, tele-surgery support.
• Oncology - MDT tumor boards, imaging/ pathology consultations, treatment planning support.

Longmaster Information & Technology Co., Ltd. (300288.SZ): How It Works

• Core platforms: an online hospital platform (integrations, SaaS and service agreements with hospitals) and the 39 Internet Hospital APP for direct patient-facing consultations and follow-up care.
• Service categories: telemedicine consultations, medical information services, video consultations, smart health monitoring (hardware + platform), pharmaceutical e-commerce and value‑added telecom/communication services.
• Channels: B2B contracts with hospitals and health systems, B2C via the 39 Internet Hospital APP, device sales to institutions and consumers, and third‑party marketplace facilitation for pharmaceuticals and consumables.

• Telemedicine and remote consultation fees - charged per consultation on the 39 Internet Hospital APP and via hospital partnerships; includes synchronous video, phone and asynchronous text/AI‑triage services.
• Online hospital and systems services - recurring SaaS/platform fees, deployment and customization fees, plus per-transaction settlement fees from hospitals using Longmaster's infrastructure.
• Smart health hardware and services - one‑time device sales (home/clinical monitoring devices) and recurring monitoring/analytics subscription revenues.
• Pharmaceutical e-commerce - commission/markup on drug and medical product sales through Longmaster's marketplace and integrated hospital pharmacies.
• Value‑added telecommunications - paid chat, messaging, data services and other communication features bundled for doctors, hospitals and patients.

• Per‑consultation billing: Patients pay a consultation fee on the 39 Internet Hospital APP; Longmaster retains a platform/service fee and remits part to clinicians/hospitals under agreed splits.
• Hospital service contracts: Multi-year platform/service agreements with hospitals generate recurring SaaS and maintenance fees, plus project implementation revenue recognized upon delivery.
• Hardware + service bundles: Devices sold to hospitals or consumers are often tied to subscription analytics/monitoring services that produce recurring revenue and higher lifetime value.
• Marketplace commissions: Pharmaceutical e‑commerce income comes from commissions, logistics fees and value‑added services (fast delivery, prescription processing) on each order.
• Value‑added telecom: Charging for premium messaging, priority routing, telephony minutes and secure communication channels for clinicians and institutions.

• Expanding hospital integrations to capture more platform fees and higher-volume transaction processing.
• Growing user base and consultation frequency on the 39 Internet Hospital APP to lift per-user monetization.
• Cross-selling devices with subscription monitoring to convert one‑time device sales into recurring revenue.
• Deepening pharmaceutical marketplace penetration to increase order volume and commission income.
• Introducing advanced paid services (AI diagnostics, premium teleconsultation tiers, enterprise messaging) to raise ARPU (average revenue per user).

Longmaster Information & Technology Co., Ltd. (300288.SZ): How It Makes Money

• Core B2B platform services: development, deployment and SaaS operation of hospital information systems, telemedicine platforms and regional health clouds.
• Third-party operations & service contracts: running provincial hospital cooperative telemedicine programs and acting as a construction/operations unit (e.g., Guizhou medical health cloud).
• AI-enabled products: clinical decision support, intelligent triage, medical image assistance and workflow automation under the "AI + Medical" strategic direction.
• Consulting, maintenance and integration services: system integration, data migration, cybersecurity and long-term maintenance contracts with hospitals and health bureaus.
• Data & analytics services: monetizing anonymized health analytics, platform usage and subscription-based reporting for institutional customers.

• Recognition: shortlisted among China's top 100 internet medical enterprises for three consecutive years, demonstrating sustained industry standing.
• Policy pilot status: designated as a pilot unit for provincial internet medical policy - enabling early access to public-sector contracts and regulatory guidance.
• Regional scale projects: construction & operations partner for the Guizhou medical health cloud and third-party operator for provincial telemedicine cooperation programs - anchoring recurring government and hospital revenue streams.
• R&D emphasis: continued investment in AI and platform development to increase product stickiness and upsell higher-margin AI services.

• Regional anchoring via provincial pilot projects (e.g., Guizhou) and third-party telemedicine operations provides stable, contract-backed revenue streams and preferential access to new public tenders.
• Strategic pivot to "AI + Medical" aims to expand higher-margin product lines (intelligent diagnostics, workflow automation) and to deepen integration into clinical pathways.
• Ongoing R&D investments and exploration of new business models and partnerships are intended to broaden service offerings, increase per-customer lifetime value and capture growth from China's digital-health policy momentum.